undefined undefined
NaN.000
NaN.00%
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates RAPT Therapeutics (NASDAQ:RAPT) with a Neutral.
04-10 18:19
RAPT Therapeutics (NASDAQ:RAPT) reported its Q4 earnings results on Thursday, M...
03-07 22:25
派拓网络隔夜期权成交49万张,较90天平均成交量放量超11倍;多头押注英特尔股价上扬,行权价在55美元,2026年12月18日到期的看涨期权成交超3.2万张>>
02-22 19:34
Latest developments in RAPT Therapeutics as FDA places clinical hold on Phase 2b trial for zelnecirnon in dermatitis and asthma. Stock rebounds and analyst downgrades.
02-22 03:04
CORRECTION: RAPT Therapeutics shares are trading higher.
02-22 00:39
© Reuters 美国股市收低;截至收盘道琼斯工业平均指数下跌0.17% 纽约收盘时,道琼斯工业平均指数下跌0.17%,而标准普尔500指数跌0.60%...
02-21 05:30
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday. The Dow traded down 0.18% to 38,557.86 while the NASDAQ fell 1.30% to 15,570.84. The S&P 500 also fell, dropping, 0.73% to 4,969.26.
02-21 03:33
Cantor Fitzgerald analyst Prakhar Agrawal downgrades RAPT Therapeutics (NASDAQ:RAPT) from Overweight to Neutral.
02-21 03:14
FDA places clinical hold on RAPT Therapeutics' Phase 2 trials for zelnecirnon in atopic dermatitis and asthma.
02-21 01:24
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 1.5% on Tuesday. The Dow traded down 0.35% to 38,494.51 while the NASDAQ fell 1.51% to 15,537.95. The S&P 500 also fell, dropping, 0.86% to 4,962.63
02-21 01:09